Star Venture-1: Series A Round
Singlera Genomics Inc., a fast growing company focusing on non-invasive genetic testing, was co-founded in July 2014 in San Diego, California by Professor Yuan Gao (Johns Hopkins University), Professor Kun Zhang (University of California at San Diego), Mr. Jiangli Zhang (CEO), Mr. Qiang Liu (COO), Dr. Rui Liu (CTO). The company currently has R&D centers and business operations at both La Jolla, California, and Shanghai., China. Singlera has proprietary technologies in single cell sequencing, DNA methylation and bioinformatics.
Star Venture-2 : Angel/Series A Round
Yet Big Data substantially changes the way we think about the world, its daunting volume, complexity and variety concerns before put to ordinary uses. The LINKSciences team has invented a series of analytical tools to solve this data dilemma.Two flagship platforms have since been developed:
- LINKSciences: help scientists do research better, faster, and cooler;
- LINKMedicine: empower ordinary patients to choose medical providers by expertise, science and confidence!
Investment: $2M (pending)
Star Venture-3 : Angel/Series A Round
3Helix has developed a series of proprietary collagen hybridizing peptides that directly target the damaged collagen molecule. In addition to providing CHP as a research tool for laboratory use in academia and industry, 3Helix is advancing its compounds to enable new pathways to achieving diagnostic and therapeutic objectives. 3Helix is based in Salt Lake City, Utah. It was founded by Drs. Yang Li and Michael Yu based on the technology that they invented at the Johns Hopkins University.
Star Venture-4: Angel/Series A Round | 落户杭州
Founded by three postdoc fellows from Johns Hopkins University, Hopstem aims at providing human iPS cell and the best neuronal models for drug discovery, screening and clinical trials of neurological disorders. Our mission is to push forward R&D of biomarkers and therapies for those who suffer from brain disorders.
Investment: $1.2 M
Star Venture-5: 新三板上市
MyGenostics Inc was established in Beijing in November 2011, focusing on the clinical and research application of next generation sequencing. Each of our products and services uses a patented technology to capture both strands of genomic target regions - this is a unique attribute and advantage of GenCapTM.
MADE IN JOHNS HOPKINS WITH LOVE AND CARE
Contact us to get full access to our project pool and the power of Hopkins invention!